Return to Lab Medicine Rounds

No Excuses

By Melissa Peterson • March 3, 2023
Related Episodes
The Final Rounds

By Melissa Peterson • July 18, 2025
Navigating Feedback: A Conversation on Growth and Communication

By Melissa Peterson • May 16, 2025
Benign Mimics of Malignant Breast Pathology

By Melissa Peterson • May 2, 2025

Melissa Peterson

Related Posts

Turning Client Activity Into Actionable Insights featured image
Turning Client Activity Into Actionable Insights
September 28, 2026

In this episode of the “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager at Mayo Clinic Laboratories, is joined by colleagues Wendy Daigle and Ellen Dijkman Dulkes to discuss managing client relationship health.

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Diagnostic criteria featured image
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): Diagnostic criteria
September 28, 2026

This microlearning reviews myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), with a focus on the 2023 International MOGAD Panel diagnostic criteria.
Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to advance diagnostics and precision medicine featured image
Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to advance diagnostics and precision medicine
September 23, 2026

Mayo Clinic Laboratories and Pathology Asia Holdings (PAH) have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medicine across Southeast Asia, Australia and New Zealand.